Table II. EAE severity of RR-EAE mice.
Peak | |||
---|---|---|---|
Treatment | No clinical score | Mild (1–2) | Severe (3–5) |
Control IgG | 10% (4/40) | 35% (14/40) | 55% (22/40) |
Anti-CD99 | 25% (10/40) | 62.5% (25/40) | 12.5% (5/40) |
Relapse | |||
---|---|---|---|
Treatment | No clinical score | Mild (1–2) | Severe (3–5) |
Control IgG | 11% (2/18) | 83% (15/18) | 6% (1/18) |
Anti-CD99 | 50% (9/18) | 50% (9/18) | 0% (0/18) |